Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)

In article number 1900605, Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for inflammation therapy. These therapies utilize a functional nanoparticle core decorated with engineered cell‐membrane vesicles. Nanoparticle co...

Full description

Saved in:
Bibliographic Details
Published inAdvanced science Vol. 6; no. 15
Main Authors Yan, Huize, Shao, Dan, Lao, Yeh‐Hsing, Li, Mingqiang, Hu, Hanze, Leong, Kam W.
Format Journal Article
LanguageEnglish
Published Hoboken John Wiley and Sons Inc 07.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In article number 1900605, Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for inflammation therapy. These therapies utilize a functional nanoparticle core decorated with engineered cell‐membrane vesicles. Nanoparticle cores that are organic (polymer), inorganic (silica and metal nanoparticle), or hybrid (such as metal–organic frameworks) in nature are all applicable. With judicious choice of cell membranes, these nanotherapeutics can achieve targeted delivery to the inflammatory environment for enhanced therapeutic efficacy.
AbstractList In article number 1900605 , Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for inflammation therapy. These therapies utilize a functional nanoparticle core decorated with engineered cell‐membrane vesicles. Nanoparticle cores that are organic (polymer), inorganic (silica and metal nanoparticle), or hybrid (such as metal–organic frameworks) in nature are all applicable. With judicious choice of cell membranes, these nanotherapeutics can achieve targeted delivery to the inflammatory environment for enhanced therapeutic efficacy.
In article number 1900605, Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for inflammation therapy. These therapies utilize a functional nanoparticle core decorated with engineered cell‐membrane vesicles. Nanoparticle cores that are organic (polymer), inorganic (silica and metal nanoparticle), or hybrid (such as metal–organic frameworks) in nature are all applicable. With judicious choice of cell membranes, these nanotherapeutics can achieve targeted delivery to the inflammatory environment for enhanced therapeutic efficacy.
Author Hu, Hanze
Lao, Yeh‐Hsing
Shao, Dan
Li, Mingqiang
Yan, Huize
Leong, Kam W.
AuthorAffiliation 4 Department of System Biology Columbia University Medical Center New York NY 10032 USA
1 Department of Biomedical Engineering Columbia University New York NY 10027 USA
2 Guangdong Provincial Key Laboratory of Liver Disease The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou Guangdong 510630 China
3 Institutes of Life Sciences School of Biomedical Science and Engineering and National Engineering Research Center for Tissue Restoration and Reconstruction South China University of Technology Guangzhou International Campus Guangzhou Guangdong 510006 China
AuthorAffiliation_xml – name: 3 Institutes of Life Sciences School of Biomedical Science and Engineering and National Engineering Research Center for Tissue Restoration and Reconstruction South China University of Technology Guangzhou International Campus Guangzhou Guangdong 510006 China
– name: 2 Guangdong Provincial Key Laboratory of Liver Disease The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou Guangdong 510630 China
– name: 4 Department of System Biology Columbia University Medical Center New York NY 10032 USA
– name: 1 Department of Biomedical Engineering Columbia University New York NY 10027 USA
Author_xml – sequence: 1
  givenname: Huize
  surname: Yan
  fullname: Yan, Huize
  organization: Columbia University
– sequence: 2
  givenname: Dan
  surname: Shao
  fullname: Shao, Dan
  organization: Columbia University
– sequence: 3
  givenname: Yeh‐Hsing
  surname: Lao
  fullname: Lao, Yeh‐Hsing
  organization: Columbia University
– sequence: 4
  givenname: Mingqiang
  surname: Li
  fullname: Li, Mingqiang
  organization: The Third Affiliated Hospital of Sun Yat‐sen University
– sequence: 5
  givenname: Hanze
  surname: Hu
  fullname: Hu, Hanze
  organization: Columbia University
– sequence: 6
  givenname: Kam W.
  surname: Leong
  fullname: Leong, Kam W.
  organization: Columbia University Medical Center
BookMark eNqFkLtOAzEQRS0UJEKgpXYJRTa29-WlQAohPCQeBYHWmrVnE6Ndb-Rdguj4BL6RLyFRUHg0VDPSzLm6Oruk42qHhBxwFnDGxADMogkE41nKmJRbpCt4JvuhjKLOj32H7DfNE2OMx2Eacdkl9S24up2hhzk-t1Y3x3TsptYheuumdIRlSW-wyj04_Hh7P4UGDf3L0LamE_BTbOmVK0qoKmht7ejh0CwCeq9tQHk8WLU72iPbBZQN7n_NHnk4H09Gl_3ru4ur0fC6r4VYloUozUQcQoQao8xgFArJmQkLncQykYZprZMCk1xLyE2qc1nkMRMZxLkREoqwR07WufPnvEKj0bUeSjX3tgL_qmqw6vfF2Zma1guVJDKO0mQZEKwDtK-bxmOxYTlTK-VqpVxtlC-BbA282BJf__lWw7PH-2_2E1pTiqc
CitedBy_id crossref_primary_10_1016_j_jconrel_2022_02_036
crossref_primary_10_1039_D0TB01063D
ContentType Journal Article
Copyright 2019 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: 2019 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID 24P
WIN
AAYXX
CITATION
5PM
DOI 10.1002/advs.201970088
DatabaseName Wiley Online Library Open Access
Wiley Online Library Free Content
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 2198-3844
EndPage n/a
ExternalDocumentID 10_1002_advs_201970088
ADVS201970088
Genre cover
GroupedDBID 0R~
1OC
24P
53G
5VS
88I
8G5
AAFWJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACGFS
ACXQS
ADBBV
ADKYN
ADZMN
ADZOD
AEEZP
AEQDE
AFBPY
AFKRA
AFPKN
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
AZQEC
BCNDV
BENPR
BPHCQ
BRXPI
CCPQU
DWQXO
EBS
EJD
GNUQQ
GODZA
GROUPED_DOAJ
GUQSH
HCIFZ
HYE
KQ8
M2O
M2P
O9-
OK1
PIMPY
PQQKQ
PROAC
ROL
RPM
WIN
AAYXX
CITATION
IAO
ITC
5PM
ID FETCH-LOGICAL-c2298-a479253a4ece49de432810d3fc65868d0ccc6fe6bc8abd7cb8fb5029a5bd28af3
IEDL.DBID RPM
ISSN 2198-3844
IngestDate Tue Sep 17 20:40:24 EDT 2024
Thu Sep 26 16:47:33 EDT 2024
Sat Aug 24 01:12:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License Attribution-NonCommercial
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2298-a479253a4ece49de432810d3fc65868d0ccc6fe6bc8abd7cb8fb5029a5bd28af3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685476/
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6685476
crossref_primary_10_1002_advs_201970088
wiley_primary_10_1002_advs_201970088_ADVS201970088
PublicationCentury 2000
PublicationDate August 7, 2019
PublicationDateYYYYMMDD 2019-08-07
PublicationDate_xml – month: 08
  year: 2019
  text: August 7, 2019
  day: 07
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Advanced science
PublicationYear 2019
Publisher John Wiley and Sons Inc
Publisher_xml – name: John Wiley and Sons Inc
SSID ssj0001537418
Score 2.1644647
Snippet In article number 1900605, Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for...
In article number 1900605 , Dan Shao, Kam W. Leong, and co‐workers summarize recent advances of rationally engineered cell membrane–based nanotherapeutics for...
SourceID pubmedcentral
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Publisher
SubjectTerms biomimetic nanomedicine
cell membrane engineering
Cover Picture
inflammation
inflammatory microenvironment
targeted drug delivery
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA86L17E-YHzixwEt0O3LknT1NscjikoghvsVvKJwuzEzZ39E_wb_UtM2q62uwjeUto05OW9vF-S934B4EIhZSysoB6OmO8RFhlPdIXwQq6ollQwpNJoiwc6HJO7STApZfFn_BDFhpuzjHS-dgbOxbzzSxrK1dLRbXej0Loxtgm2LLZhTq8RefzdZQmwo2dxN8zZ1bWHGSEr5kYfdaq_qHim9QjJMnJNXc9gF-zkmBH2skGugw2d7IF6bpVz2Mypo1v7YGYny3JK1fwKlggHYV9Pp_Bev9puJ_r78-vaujAF1-vAxQyO0gBxeJsYqzFZdiNs9tSyDW2zbdgNOq5DrQMwHtyM-kMvv1LBkwhZAXASRijAnGipSaQ0wYh1fYWNtEiEMuVLKanRVEjGhQqlYEYEPop4IBRi3OBDUEtmiT4CkBFJDFJ2fWIL1IQCa98g444lKcOaNsDlSpzxW8acEWccySh2go8LwTdAWJF28bmjvq6-SV6eUwpsSllAQtsGSsfljwZi6-Kfiqfj_1Q6AduunIb-haegtnj_0GcWjizEeapxP2XX2mM
  priority: 102
  providerName: Wiley-Blackwell
Title Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fadvs.201970088
https://pubmed.ncbi.nlm.nih.gov/PMC6685476
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB5sT17E-sD6KHsQ1EOadHezu_FWi1IFRVDBW8i-sNCmxdae_Qn-Rn-Jm01aWi-Ct4RkM8nMJt8M-eZbgFONtXVpBQtIIqKAisQGsiNlwDPNjGJSYO3ZFg-s_0LvXuPXDYgXvTCetK_koJ0PR-188Oa5lZORChc8sfDxvseYiClnYQ1qnJCVEr1sDSaFIstCoDHCYabnhTB3J-EO8MQaAP0mQq4mqB5hbrZhq0oNUbe8hQZsmHwHGtXLN0XnlUL0xS6M3TdxtXNqeolWdAVRzwyH6N6MXCGcm-_PryuHVBr9HoNmY_TseeDoNrduYpRNjOi8q-dt5My2UScOiwe62IOXm-vnXj-oVk4IFMaJCDLKExyTjBplaKINJVh0Ik2scgkHEzpSSjFrmFQik5orKayMI5xksdRYZJbsQz0f5-YAkKCKWqxdGeI2mOWSmMhiW_x9ZIIY1oSzhTvTSSmQkZZSyDgtHJ8uHd8Evubt5emFwvX6ERd4r3RdBboJ2MflDwOpQ_Kn5d7hv80dwWZxFU_z48dQn71_mBOXesxkC2qYPrZ84d7y0-4HBVnd4Q
link.rule.ids 230,315,733,786,790,870,891,11589,27955,27956,46085,46509,50847,50956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1JTwIxFIAbxYNejLhEXHswEQ4DQ9vpdLwhkYACMRESb5PpFk1wMIKc_Qn-Rn-J7QwMDBcTb7N1mr4u7_X19SsAVxJJbcwK6uCAuQ5hgXZ4nXPHjyRVgnKGZBJt0aftIbl_9hbRhHYvTMqHyBxutmck47Xt4NYhXVtSQyM5s7zteuAbPcY2wRaxNDgLdyaPSzeLhy2fxR4xZ6bXDmaELNCNLqrlf5FTTeshkquma6J7Wntgd240wkZay0WwoeJ9UJx3ywksz9nRlQMwNqPl6p6qyQ1cIQ7CphqNYE-9mXLH6ufr-9boMAnX08DpGA6SCHHYibVpMun2RlhuyFkVmmyrsO7VbIEqh2DYuhs02878TAVHIGQEEBE_QB6OiBKKBFIRjFjdlVgLY4pQJl0hBNWKcsEiLn3Bmeaei4LI4xKxSOMjUIjHsToGkBFBNJJmgmIuqPY5Vq5G2q5LUoYVLYHrhTjD9xSdEaaQZBRawYeZ4EvAz0k7-9yyr_Nv4teXhIFNKfOIb_JASb38kUFodPxTdnfyn0SXYLs96HXDbqf_cAp27PMkDtA_A4Xpx6c6N7bJlF8kre8XLzbdyw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELWgSIgLoiyirD4gAYfQ1HYch1spVGUVEhRVXKJ4E0glrWjpmU_gG_kSxkkoLRckbtmckcfLvLFnnhHa00RbgBXco5HwPSYi68malF6YaG4Ul4LoLNrihrfa7KITdCay-HN-iPGCmxsZ2XztBnhf2-oPaWiiR45uuxaFYMbELJoDqMHA_ZqrP7Qf2z_rLAF1BC3ujDnwrz0qGPvmbvRJdfonU7bpd4zkJHbNjE9zCS0WqBHX82YuoxmTLqNyMS4H-KAgjz5cQT2YLieTqgbHeIJyEDdMt4uvzQtUPDWf7x8nYMQ0_l0GD3v4PgsRx-ephT6T5zfig7oeHWEQe4RrQdVV6HAVtZtn942WVxyq4ClCQAEJCyMS0IQZZVikDaNE1HxNrQIswoX2lVLcGi6VSKQOlRRWBj6JkkBqIhJL11Ap7aVmHWHBFLNEg4cCF9yGkhrfEus2JrmghlfQ_rc6437OnRHnLMkkdoqPx4qvoHBK2-PPHfn19Jv0-SkjweZcBCwEGSRrlz8ExGDk78Z3G_8ptIvmb0-b8dX5zeUmWnCPszjAcAuVhq9vZhuwyVDuFN3vCzKY3sM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanotherapeutics%3A+Engineering+Cell+Membrane%E2%80%90Based+Nanotherapeutics+to+Target+Inflammation+%28Adv.+Sci.+15%2F2019%29&rft.jtitle=Advanced+science&rft.au=Yan%2C+Huize&rft.au=Shao%2C+Dan&rft.au=Lao%2C+Yeh%E2%80%90Hsing&rft.au=Li%2C+Mingqiang&rft.date=2019-08-07&rft.issn=2198-3844&rft.eissn=2198-3844&rft.volume=6&rft.issue=15&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fadvs.201970088&rft.externalDBID=10.1002%252Fadvs.201970088&rft.externalDocID=ADVS201970088
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2198-3844&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2198-3844&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2198-3844&client=summon